PMM2-CDG
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG (NCT06892288) | Glycomine, Inc. | 2025-07-09 |
| Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients (NCT06657859) | Glycomine, Inc. | 2024-09-30 |
| 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG (NCT05549219) | Glycomine, Inc. | 2022-11-29 |
| Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG (NCT04925960) | Maggie's Pearl, LLC | 2022-11-10 |
| Acetazolamide Efficacy in Ataxia in PMM2-CDG (NCT04679389) | Mayo Clinic | 2021-03-17 |
Track PMM2-CDG automatically
Every clearance here is in the API, with alerts when new ones post.